These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38827826)

  • 1. Cholera resurgence in Africa: assessing progress, challenges, and public health response towards the 2030 global elimination target.
    Amisu BO; Okesanya OJ; Adigun OA; Manirambona E; Ukoaka BM; Lawal OA; Idris NB; Olaleke NO; Okon II; Ogaya JB; Prisno DEL
    Infez Med; 2024; 32(2):148-156. PubMed ID: 38827826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-vaccine strategies for cholera prevention and control: India's preparedness for the global roadmap.
    Das M; Singh H; Girish Kumar CP; John D; Panda S; Mehendale SM
    Vaccine; 2020 Feb; 38 Suppl 1():A167-A174. PubMed ID: 31443992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of cholera hotspots in Kenya using epidemiologic and water, sanitation, and hygiene (WASH) indicators as part of Kenya's new 2022-2030 cholera elimination plan.
    Kiama C; Okunga E; Muange A; Marwanga D; Langat D; Kuria F; Amoth P; Were I; Gachohi J; Ganda N; Martinez Valiente M; Njenga MK; Osoro E; Brunkard J
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011166. PubMed ID: 36930650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral killed cholera vaccines for preventing cholera.
    Saif-Ur-Rahman KM; Mamun R; Hasan M; Meiring JE; Khan MA
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD014573. PubMed ID: 38197546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholera outbreaks in Africa.
    Mengel MA; Delrieu I; Heyerdahl L; Gessner BD
    Curr Top Microbiol Immunol; 2014; 379():117-44. PubMed ID: 24827501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fight against cholera outbreak, efforts and challenges in Malawi.
    Miggo M; Harawa G; Kangwerema A; Knovicks S; Mfune C; Safari J; Kaunda JT; Kalua J; Sefu G; Phiri E; Patel P
    Health Sci Rep; 2023 Oct; 6(10):e1594. PubMed ID: 37808935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2023 Latin America report of the
    Hartinger SM; Palmeiro-Silva YK; Llerena-Cayo C; Blanco-Villafuerte L; Escobar LE; Diaz A; Sarmiento JH; Lescano AG; Melo O; Rojas-Rueda D; Takahashi B; Callaghan M; Chesini F; Dasgupta S; Posse CG; Gouveia N; Martins de Carvalho A; Miranda-Chacón Z; Mohajeri N; Pantoja C; Robinson EJZ; Salas MF; Santiago R; Sauma E; Santos-Vega M; Scamman D; Sergeeva M; Souza de Camargo T; Sorensen C; Umaña JD; Yglesias-González M; Walawender M; Buss D; Romanello M
    Lancet Reg Health Am; 2024 May; 33():100746. PubMed ID: 38800647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditions to eliminate cholera in Mozambique - the pathway for the development of the national cholera plan.
    Baltazar CS; Pezzoli L; Baloi LD; Luiz N; Chitio JE; Capitine I; Sitoe M; Mala S; Langa JP
    Pan Afr Med J; 2022; 42():279. PubMed ID: 36405663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera: ancient scourge on the rise. WHO announces global plan for cholera control. (25 April 1991).
    World Health Organization WHO. Office of Information
    WHO Feature; 1991 Apr; (154):1-3. PubMed ID: 12317930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines.
    Baik YO; Choi SK; Olveda RM; Espos RA; Ligsay AD; Montellano MB; Yeam JS; Yang JS; Park JY; Kim DR; Desai SN; Singh AP; Kim IY; Kim CW; Park SN
    Vaccine; 2015 Nov; 33(46):6360-5. PubMed ID: 26348402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030.
    Legros D;
    J Infect Dis; 2018 Oct; 218(suppl_3):S137-S140. PubMed ID: 30184102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
    Song KR; Chapagain RH; Tamrakar D; Shrestha R; Kanodia P; Chaudhary S; Wartel TA; Yang JS; Kim DR; Lee J; Park EL; Cho H; Lee J; Thaisrivichai P; Vemula S; Kim BM; Gupta B; Saluja T; Pansuriya RK; Ganapathy R; Baik YO; Lee YJ; Jeon S; Park Y; Her HL; Park Y; Lynch JA
    Lancet Glob Health; 2024 May; 12(5):e826-e837. PubMed ID: 38614631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-Border Cholera Outbreaks in Sub-Saharan Africa, the Mystery behind the Silent Illness: What Needs to Be Done?
    Bwire G; Mwesawina M; Baluku Y; Kanyanda SS; Orach CG
    PLoS One; 2016; 11(6):e0156674. PubMed ID: 27258124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, Management, and Future Control of Cholera.
    Chowdhury F; Ross AG; Islam MT; McMillan NAJ; Qadri F
    Clin Microbiol Rev; 2022 Sep; 35(3):e0021121. PubMed ID: 35726607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera vaccine.
    Terrinoni M; Nordqvist SL; Löfstrand M; Nilsson F; Källgård S; Sharma T; Lebens MR; Holmgren J
    Vaccine; 2023 May; 41(21):3347-3357. PubMed ID: 37085452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends of major disease outbreaks in the African region, 2003-2007.
    Kebede S; Duales S; Yokouide A; Alemu W
    East Afr J Public Health; 2010 Mar; 7(1):20-9. PubMed ID: 21413568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera past and future in Nigeria: Are the Global Task Force on Cholera Control's 2030 targets achievable?
    Charnley GEC; Yennan S; Ochu C; Kelman I; Gaythorpe KAM; Murray KA
    PLoS Negl Trop Dis; 2023 May; 17(5):e0011312. PubMed ID: 37126498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholera prevention, control strategies, challenges and World Health Organization initiatives in the Eastern Mediterranean Region: A narrative review.
    Buliva E; Elnossery S; Okwarah P; Tayyab M; Brennan R; Abubakar A
    Heliyon; 2023 May; 9(5):e15598. PubMed ID: 37153427
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.